Bouncing back: Is the bipolar rebound phenomenon peculiar to lithium? A retrospective naturalistic study

Journal of Psychopharmacology

Volumn 22, Issue 4, 2008, Pages 452-456

  Franks, M A ^a   Macritchie, K A N ^a   Mahmood, T ^b   Young, A H ^c  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b LEEDS AND YORK PARTNERSHIP NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Bipolar disorder; Naturalistic; Rebound episode; Retrospective

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; CARBAMAZEPINE; FLUOXETINE; LITHIUM; NEUROLEPTIC AGENT; OLANZAPINE; REBOXETINE; TRAZODONE; VALPROIC ACID; ZUCLOPENTHIXOL DECANOATE;

ARTICLE; BIPOLAR DISORDER; BIPOLAR I DISORDER; CLINICAL PRACTICE; CLINICAL RESEARCH; DRUG WITHDRAWAL; EVIDENCE BASED MEDICINE; HOSPITALIZATION; HUMAN; HYPOMANIA; MAJOR CLINICAL STUDY; MANIA; PRIORITY JOURNAL; REBOUND; RECURRENT DISEASE; RETROSPECTIVE STUDY;

ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; ANTIMANIC AGENTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; DEPRESSIVE DISORDER; HUMANS; LITHIUM COMPOUNDS; RECURRENCE; RETROSPECTIVE STUDIES; RISK; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 47249098963     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881107085238     Document Type: Article

References (15)

1. Altshuler, L., Suppes, T., Black, D., Nolen, WA, Keck, PE, Frye, MA et al. (2003) Impact of antidepressant discontinuation after acute bipolar depression remission on rates of depressive relapse at 1-year follow up. Am J Psychiatry 160: 1252-1262.
2. Baastrup, PC, Poulsen, JC, Schou, M., Thomsen, K., Amdisen, A. (1970) Prophylactic lithium: double blind discontinuation in manic-depressive and recurrent depressive disorders. Lancet 2: 326-330.
3. Baldessarini, RJ, Tondo, L., Viguera, AC (1999) Discontinuing lithium maintenance treatment in bipolar disorders: risks and implications. Bipolar Disord 1: 17-24.
4. Ferrier, IN, Thompson, JM (2002) Cognitive impairment in bipolar affective disorder: implications for the bipolar diathesis. Br J Psychiatry 180: 293-295.
5. Franks, MA, Macritchie, KAN, Young, AH (2005) The consequences of suddenly stopping psychotropic medication in bipolar disorder. Clin Approaches Bipolar Disord 4: 11-17.
6. Goodwin, GM (1994) Recurrence of mania after lithium withdrawal: implications for the use of lithium in the treatment of bipolar affective disorder. Br J Psychiatry 164: 149-152.
7. Goodwin, GM (2003) Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology. J Psychopharmacol 17: 149-173.
8. Macritchie, KAN, Hunt, NJ (2000) Does 'rebound mania' occur after stopping carbamazepine? A pilot study. J Psychopharmacol 14: 266-268.
9. Mander, AJ (1986) Is there a lithium withdrawal syndrome. Br J Psychiatry 149: 498-501.
10. Mander, AJ, Loudon, JB (1988) Rapid recurrence of mania following abrupt discontinuation of lithium. Lancet 2: 15-17.
11. Melia, PI et al (1970) Prophylactic lithium: a double blind trial in recurrent affective disorders. Br J Psychiatry 116: 621-624.
12. Suppes, T., Baldessarini, RJ, Fredda, GL, Tohen, M. (1991) Risk of recurrence following discontinuation of lithium treatment in bipolar disorder. Arch Gen Psychiatry 48: 1082-1088.
13. Tohen, M., Calabrese, JR, Sachs, GS, Banov, MD, Detke, HC, Risser, R., Baker, RW, Chou, JC, Bowden, CL (2006) Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine. Am J Psychiatry 163: 247-256.
14. Tyrer, S. (2006) What does history teach us about factors associated with relapse in bipolar disorder ? J Psychopharmacol 20: 4-11.
15. Young, AH, Haddad, P. (2001) Discontinuation symptoms and psychotropic drugs. Lancet 1355: 1184.